The gut-microbiome contribution to HIV-associated cardiovascular disease and metabolic disorders

Simple item page
dc.contributor.authorChachage, Mkunde
dc.date.accessioned2022-11-23T09:11:04Z
dc.date.available2022-11-23T09:11:04Z
dc.date.issued2021-12
dc.description.abstractDuring the past decade, there has been a great effort in characterizing the gut microbiome of individuals living with HIV and its influence on HIV-metabolic disorders. Herein, the current understanding of the changes in the composition and function of the gut microbiome in the context of HIV infection, cardiovascular disease, and HIV-associated metabolic disorders is reviewed. A focus is especially given to bacteria gut microbiome and their produced metabolites, including tryptophan, short-chain fatty acids, and trimethylamine-N-oxide, and discuss current literatures that have investigated their role in HIV pathogenesis and HIV metabolic disorders. This review finally calls for future studies to focus on interrogating the mechanism of host-gut microbiome interaction in relation to HIV and HIV comorbidities by using multiomics approaches and on geographically diverse populations.en_US
dc.description.sponsorshipNoneen_US
dc.identifier.citationMkunde Chachage, The gut-microbiome contribution to HIV-associated cardiovascular disease and metabolic disorders, Current Opinion in Endocrine and Metabolic Research, Volume 21, 2021, 100287, ISSN 2451-9650, https://doi.org/10.1016/j.coemr.2021.100287. (https://www.sciencedirect.com/science/article/pii/S2451965021000843) Abstract: During the past decade, there has been a great effort in characterizing the gut microbiome of individuals living with HIV and its influence on HIV-metabolic disorders. Herein, the current understanding of the changes in the composition and function of the gut microbiome in the context of HIV infection, cardiovascular disease, and HIV-associated metabolic disorders is reviewed. A focus is especially given to bacteria gut microbiome and their produced metabolites, including tryptophan, short-chain fatty acids, and trimethylamine-N-oxide, and discuss current literatures that have investigated their role in HIV pathogenesis and HIV metabolic disorders. This review finally calls for futMkunde Chachage, The gut-microbiome contribution to HIV-associated cardiovascular disease and metabolic disorders, Current Opinion in Endocrine and Metabolic Research, Volume 21, 2021, 100287, ISSN 2451-9650, https://doi.org/10.1016/j.coemr.2021.100287.en_US
dc.identifier.issn2451-9650
dc.identifier.urihttp://hdl.handle.net/20.500.11810/5904
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectGut microbiome; HIV; Epithelia barrier; Cardiovascular disease; Metabolic disordersen_US
dc.titleThe gut-microbiome contribution to HIV-associated cardiovascular disease and metabolic disordersen_US
dc.typeJournal Article, Peer Revieweden_US
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Chachage 2021.pdf
Size:
9.3 MB
Format:
Adobe Portable Document Format
Description:
Download
Thumbnail Image
Name:
Chachage 2021.pdf
Size:
9.3 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Department of Microbiology/Immunology